Forte Biosciences, Inc. (FBRX)

NASDAQ: FBRX · IEX Real-Time Price · USD

0.780

+0.040 (5.39%)

At close: Apr 18, 2024, 4:00 PM

0.752

-0.028 (-3.64%)

After-hours: Apr 18, 2024, 6:41 PM EDT

Forte Biosciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015
Net Income	-31.48	-13.88	-21.71	-46.49	-4.07	-48.96	-38.93	-33.48	-23.06
Depreciation & Amortization	0.01	0	0.04	0.05	0.01	0.63	0.29	0.26	0.23
Share-Based Compensation	3.28	4.02	4.21	0.96	0.04	6.87	4.45	1.32	1.06
Other Operating Activities	-0.52	1.68	0.78	27.05	1.25	6.99	3.05	2.36	0.72
Operating Cash Flow	-28.71	-8.19	-16.68	-18.42	-2.77	-34.47	-31.13	-29.54	-21.04
Capital Expenditures	-0.09	0	0	0	-0.16	-1.97	-0.64	-0.53	-0.22
Acquisitions	0	0	0	3.58	0	0	0	0	0
Change in Investments	0.14	0	0	0	0	-2.22	-27.07	25.09	-24.71
Investing Cash Flow	0.05	0	0	3.58	-0.16	-4.19	-27.71	24.57	-24.93
Share Issuance / Repurchase	24.74	7.24	0.06	66.96	0	28.86	89.13	0.01	0.16
Debt Issued / Paid	0	0	0	0	0	14.69	0.14	2.91	17.67
Other Financing Activities	-0.06	-	-0.11	-0.29	4.86	-0.02	-	-0.59	32.09
Financing Cash Flow	24.68	7.24	-0.04	66.67	4.86	43.54	89.26	2.33	49.92
Net Cash Flow	-3.98	-0.94	-16.72	51.83	1.92	4.88	30.42	-2.64	3.95
Free Cash Flow	-28.79	-8.19	-16.68	-18.42	-2.93	-36.44	-31.77	-30.06	-21.26
Free Cash Flow Margin	-	-	-	-	-	-202.02%	-77482.93%	-61355.10%	-41682.35%
Free Cash Flow Per Share	-0.91	-0.47	-1.19	-2.50	-1.39	-27.25	-32.62	-204.98	-146.13

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).